CEO of AVEO Pharmaceuticals Inc. (AVEO, Financial) Ngoc Tuan Ha sells 3,300 shares of AVEO on 04/28/2011 at an average price of $16.04 a share.
Aveo Pharmaceuticals Inc. has a market cap of $556.88 million; its shares were traded at around $15.56 with a P/E ratio of 17.68 and P/S ratio of 12.46.
For the complete insider trading history of AVEO, click here.
Aveo Pharmaceuticals Inc. has a market cap of $556.88 million; its shares were traded at around $15.56 with a P/E ratio of 17.68 and P/S ratio of 12.46.
Directors and Officers Recent Trades:
- Buy: Director Raju S Kucherlapati bought 15,000 shares of AVEO stock on 03/15/2011 at the average price of 14.44. Raju S Kucherlapati owns at least 175,415 shares after this. The price of the stock has increased by 7.76% since.
- Sell: Chief Medical Officer William Slichenmyer sold 2,000 shares of AVEO stock on 04/19/2011 at the average price of 13.71. William Slichenmyer owns at least 6,000 shares after this. The price of the stock has increased by 13.49% since.
- Sell: Chief Business Officer Elan Ezickson sold 10,000 shares of AVEO stock on 04/11/2011 at the average price of 13.63. Elan Ezickson owns at least 26,000 shares after this. The price of the stock has increased by 14.16% since.
- Sell: Chief Medical Officer William Slichenmyer sold 1,000 shares of AVEO stock on 03/18/2011 at the average price of 15. William Slichenmyer owns at least 6,000 shares after this. The price of the stock has increased by 3.73% since.
- Sell: Chief Business Officer Elan Ezickson sold 7,500 shares of AVEO stock on 03/16/2011 at the average price of 14.42. Elan Ezickson owns at least 36,000 shares after this. The price of the stock has increased by 7.91% since.
For the complete insider trading history of AVEO, click here.
